Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Revenue		$ 3,658
Operating expenses:
General and administrative (including stock-based compensation (Note 7))	1,655,734	1,816,341
Depreciation	1,981	293,577
Impairment loss on property and equipment		1,684,562
Research and development (including stock-based compensation (Note 7))	425,983	348,559
Total operating expenses	2,083,698	4,143,039
Loss from operations	(2,083,698)	(4,139,381)
Other expense:
Interest expense, net	379,189	382,686
Total interest expense	379,189	382,686
Net loss	(2,462,887)	(4,522,067)
Net loss attributable to the noncontrolling interest	2,414	3,634
Net loss applicable to Bion's common stockholders	$ (2,460,473)	$ (4,518,433)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in dollars per share)	$ (0.10)	$ (0.20)
Weighted-average number of common shares outstanding:
Basic and diluted (in shares)	23,459,931	22,745,281